Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Domain-

RNF168 KMT2B TRIM35

2.58e-034491233.30.40.10
DomainZnf_RING/FYVE/PHD

RNF168 KMT2B TRIM35

2.75e-03459123IPR013083
DomainZnf_C3HC4_RING-type

RNF168 TRIM35

5.24e-03172122IPR018957
Domainzf-C3HC4

RNF168 TRIM35

8.66e-03223122PF00097
DomainZF_RING_1

RNF168 TRIM35

1.44e-02291122PS00518
DomainZF_RING_2

RNF168 TRIM35

1.51e-02298122PS50089
DomainRING

RNF168 TRIM35

1.57e-02305122SM00184
DomainZnf_RING

RNF168 TRIM35

1.79e-02326122IPR001841
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SZT2 ANAPC2 TBC1D2B TRIM35

2.38e-0552912414621295
Pubmed

Functional proteomics mapping of a human signaling pathway.

LEMD3 ANAPC2 RNF168 KMT2B

3.67e-0559112415231748
Pubmed

Lineage-specific biology revealed by a finished genome assembly of the mouse.

SZT2 FER1L5

1.60e-045512219468303
GeneFamilyRing finger proteins

RNF168 TRIM35

7.73e-032759258
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TBC1D2B FGF22 TRIM35

1.18e-0517212394093d356b0252b440deda4e1b0ac332b31513f6
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZHX3 KMT2B TBC1D2B

1.30e-05178123c87945146b2734141f07b39d268e0d8086ee0364
ComputationalBreast cancer expression clusters.

SZT2 TBC1D2B

2.69e-0314762MODULE_195
ComputationalGenes in the cancer module 356.

SZT2 TBC1D2B

2.80e-0315062MODULE_356
DrugIsocarboxazid [59-63-2]; Down 200; 17.2uM; HL60; HT_HG-U133A

SZT2 ZHX3 KMT2B TBC1D2B

2.65e-061991242562_DN
DiseaseS-7-hydroxywarfarin to S-warfarin ratio measurement

LEMD3 RNF168

4.83e-0481122EFO_0803334
Diseaseeosinophil percentage of leukocytes

P2RY8 ANAPC2 KMT2B

2.99e-03746123EFO_0007991
Diseaseneuroimaging measurement

SZT2 ZHX3 KMT2B

8.16e-031069123EFO_0004346
Diseasetotal blood protein measurement

RNF168 TBC1D2B

1.38e-02449122EFO_0004536

Protein segments in the cluster

PeptideGeneStartEntry
LRRWRCHVQRFFYRI

ANAPC2

321

Q9UJX6
SKRWRRRRYAVAACA

P2RY8

131

Q86VZ1
WCRFRRAFVTVTHRL

LEMD3

621

Q9Y2U8
RWRRLFSSTHFFLRV

FGF22

41

Q9HCT0
STVDARRRCWYRCRI

KMT2B

1766

Q9UMN6
TTCYRGRHRRFRLDW

KIFC2

436

Q96AC6
IRSLYRTHVIRRFWN

SZT2

481

Q5T011
RWTSYRFSRVCRLHR

TRIM35

91

Q9UPQ4
KTYHSCRRRRWARVR

FER1L5

936

A0AVI2
CPFCRRRVSSWTRYH

RNF168

51

Q8IYW5
RRVSSWTRYHTRRNS

RNF168

56

Q8IYW5
REVRKWFSDRRYHCR

ZHX3

536

Q9H4I2
RGYRSRWFVFDARRC

TBC1D2B

51

Q9UPU7